At the rate of which new institutions are requesting to do studies on kevetrin one would think Cellceutix should start charging for the study material - say a couple million for each study batch of kevetrin?

Oh wait! If a study costs a couple million, that would have come out of Cellceutix funds, but the institutions are funding the studies. Hmm... pay 2 million to get kevetrin, Cellceutix pays 2 million for the study - 2 minus 2 equals 0 -or- get kevetrin for free, pay zero million for the study - 0 minus 0 equals 0.  Meh, six or half dozen either way